Boxer Capital as of Sept. 30, 2016
Portfolio Holdings for Boxer Capital
Boxer Capital holds 28 positions in its portfolio as reported in the September 2016 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Clovis Oncology | 16.2 | $36M | 1.0M | 36.05 | |
Medicines Company | 11.8 | $26M | 700k | 37.74 | |
Blueprint Medicines (BPMC) | 9.4 | $21M | 705k | 29.70 | |
Medicines | 9.3 | $21M | 550k | 37.74 | |
Beigene (BGNE) | 6.8 | $15M | 494k | 30.81 | |
Seattle Genetics | 5.6 | $13M | 233k | 54.01 | |
Avexis | 5.5 | $12M | 300k | 41.21 | |
Aquinox Pharmaceuticals | 5.3 | $12M | 878k | 13.36 | |
Incyte Corporation (INCY) | 4.2 | $9.4M | 100k | 94.29 | |
BioMarin Pharmaceutical (BMRN) | 4.2 | $9.3M | 100k | 92.52 | |
Aradigm | 2.9 | $6.4M | 931k | 6.88 | |
Acadia Pharmaceuticals | 2.9 | $6.4M | 201k | 31.81 | |
Mirati Therapeutics | 2.2 | $5.0M | 758k | 6.61 | |
Rigel Pharmaceuticals (RIGL) | 2.2 | $5.0M | 1.4M | 3.67 | |
Syndax Pharmaceuticals (SNDX) | 1.6 | $3.6M | 234k | 15.16 | |
Tesaro | 1.6 | $3.5M | 35k | 100.23 | |
Heron Therapeutics (HRTX) | 1.5 | $3.4M | 200k | 17.23 | |
Kura Oncology (KURA) | 1.5 | $3.3M | 533k | 6.25 | |
Aldeyra Therapeutics (ALDX) | 1.0 | $2.3M | 291k | 7.85 | |
Eleven Biotherapeutics | 0.9 | $2.1M | 750k | 2.80 | |
Eiger Biopharmaceuticals | 0.8 | $1.9M | 138k | 13.39 | |
Array BioPharma | 0.6 | $1.4M | 200k | 6.75 | |
Nabriva Therapeutics | 0.6 | $1.2M | 177k | 7.05 | |
Akari Therapeutics | 0.5 | $1.2M | 140k | 8.51 | |
Onconova Therapeutics | 0.4 | $838k | 316k | 2.65 | |
Nexvet Biopharma Pub Ltd Co ord | 0.3 | $643k | 155k | 4.15 | |
Onconova Therapeutics Inc *w exp 07/07/202 | 0.1 | $242k | 242k | 1.00 | |
Essa Pharma | 0.0 | $74k | 28k | 2.63 |